Home > Authorities > Grants > Record #210663 > print

001     210663
005     20230208173807.0
024 7 _ |a G:(EU-Grant)730983
|d 730983
|2 CORDIS
024 7 _ |a G:(EU-Call)H2020-INFRAIA-2017-1-two-stage
|d H2020-INFRAIA-2017-1-two-stage
|2 CORDIS
024 7 _ |a corda__h2020::730983
|2 originalID
035 _ _ |a G:(EU-Grant)730983
150 _ _ |a INfraStructure in Proton International REsearch
|y 2018-03-01 - 2022-12-31
371 _ _ |a Ion Beam Applications (Belgium)
|b Ion Beam Applications (Belgium)
|d Belgium
|v CORDIS
371 _ _ |a THE HENRYK NIEWODNICZANSKI INSTITUTE OF NUCLEAR PHYSICS, POLISH ACADEMY OF SCIENCES
|b IFJ PAN
|d Poland
|e http://www.ifj.edu.pl
|v CORDIS
371 _ _ |a Aarhus University
|b AU
|d Denmark
|e http://www.au.dk/en/
|v CORDIS
371 _ _ |a THE CHRISTIE NHS FOUNDATION TRUST
|b THE CHRISTIE
|d United Kingdom
|e http://www.christie.nhs.uk
|v CORDIS
371 _ _ |a Paul Scherrer Institute
|b PSI
|d Switzerland
|e http://www.psi.ch/
|v CORDIS
371 _ _ |a INTERNET-SIMULATION EVALUATION ENVISION SRL
|b I-SEE
|d Italy
|e http://www.i-seecomputing.com
|v CORDIS
371 _ _ |a USTAV JADERNE FYZIKY AV CR
|b NUCLEAR PHYSICS INSTITUTE OF THE CAS VVI
|d Czech Republic
|e http://www.ujf.cas.cz
|v CORDIS
371 _ _ |a KOMMUNALFORBUNDET AVANCERAD STRALBEHANDLING
|d Sweden
|e http://www.skandionkliniken.se
|v CORDIS
371 _ _ |a VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH
|d Germany
|e https://www.varian.com/oncology/solutions/proton-therapy
|v CORDIS
371 _ _ |a ACADEMISCH ZIEKENHUIS GRONINGEN
|b UNIVERSITAIR MEDISCH CENTRUM GRONINGEN
|d Netherlands
|e http://www.umcg.nl
|v CORDIS
371 _ _ |a TU Dresden
|b TUD
|d Germany
|e http://tu-dresden.de/en
|v CORDIS
371 _ _ |a UNIVERSITE DE NAMUR ASBL
|b UNamur
|d Belgium
|e http://www.unamur.be
|v CORDIS
371 _ _ |a Institute Curie
|b Institute Curie
|d France
|e http://www.institut-curie.org/
|v CORDIS
371 _ _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|b GSI
|d Germany
|e http://www.gsi.de/
|v CORDIS
371 _ _ |a University of Manchester
|b University of Manchester
|d United Kingdom
|e http://www.manchester.ac.uk/
|v CORDIS
371 _ _ |a National Institute for Nuclear Physics
|b INFN
|d Italy
|e http://www.infn.it/index.php?lang=en
|v CORDIS
371 _ _ |a University of Groningen
|b University of Groningen
|d Netherlands
|e http://www.rug.nl/
|v CORDIS
371 _ _ |a LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS
|b LSMU
|d Lithuania
|e http://www.lsmuni.lt
|v CORDIS
372 _ _ |a H2020-INFRAIA-2017-1-two-stage
|s 2018-03-01
|t 2022-12-31
450 _ _ |a INSPIRE
|w d
|y 2018-03-01 - 2022-12-31
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a Proton beam therapy (PBT) is a radical new type of advanced radiotherapy, capable of delivering and conforming a targeted dose of radiation to the tumour while causing minimal damage to the surrounding healthy tissue. In the past 5 years there has been a huge investment in high energy PBT across Europe and eleven member states now either have PBT in operation or are developing this capability. In addition, the two largest manufactures of PBT equipment have based their manufacturing in Europe. This integrating activity INSPIRE, aims to link these clinical PBT centres in eleven different countries together with two associated centres in USA. It also brings in two of the worlds largest manufacturers of PBT equipment and an SME. The trans-national access in INSPIRE will provide European researchers with access to “state of the art” research capabilities employing proton beams at clinical energies. INSPIRE represents an integrating activity across Europe in a multi-disciplinary field that is growing exponentially. Through its Networking, Transnational Access and Joint Research Activities, INSPIRE seeks to provide the “state of the art” capabilities that are needed to address the key challenges in this rapidly developing field. INSPIRE has at its heart the principles of responsible research and innovation and will communicate its research and give access to its databases and software through an Open Access Gateway. INSPIRE will contain a pipeline of innovation through its Innovation Gateway, to accelerate research for patient and commercial benefit. INSPIRE will provide its researchers with an unrivalled research and training and opportunities to “discipline hop” into the industrial, clinical or industrial environment. INSPIRE integrates activities across Europe in this rapidly growing area and offers European researchers unrivalled access to state of the art research capabilities in an area where there has already been significant government investment.
909 C O |o oai:juser.fz-juelich.de:846754
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:846754
970 _ _ |a oai:dnet:corda__h2020::3e809f48564a76a1394b584892446443
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21